AU4479700A - Nucleic acid immunization - Google Patents

Nucleic acid immunization Download PDF

Info

Publication number
AU4479700A
AU4479700A AU44797/00A AU4479700A AU4479700A AU 4479700 A AU4479700 A AU 4479700A AU 44797/00 A AU44797/00 A AU 44797/00A AU 4479700 A AU4479700 A AU 4479700A AU 4479700 A AU4479700 A AU 4479700A
Authority
AU
Australia
Prior art keywords
nucleic acid
use according
sequence
particles
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44797/00A
Other languages
English (en)
Inventor
Dexiang Chen
James T. Fuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of AU4479700A publication Critical patent/AU4479700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AU44797/00A 1999-04-21 2000-04-21 Nucleic acid immunization Abandoned AU4479700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13024999P 1999-04-21 1999-04-21
US60130249 1999-04-21
PCT/US2000/010766 WO2000063385A2 (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Publications (1)

Publication Number Publication Date
AU4479700A true AU4479700A (en) 2000-11-02

Family

ID=22443785

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44797/00A Abandoned AU4479700A (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Country Status (6)

Country Link
EP (1) EP1180150A2 (de)
JP (1) JP2002542264A (de)
AU (1) AU4479700A (de)
CA (1) CA2370646A1 (de)
NZ (1) NZ515041A (de)
WO (1) WO2000063385A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392365A2 (de) * 2000-11-02 2004-03-03 Powderject Vaccines, Inc. Zusammensetzungen und therapeutische verwendung von polynukleotiden, die für tcr kodieren
CN1842349A (zh) * 2003-08-29 2006-10-04 安琪士摩奇株式会社 使用无针注射器进行皮肤疾病基因治疗
WO2006027244A2 (en) * 2004-09-10 2006-03-16 Bracco Imaging S.P.A. Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides
WO2006133497A1 (en) * 2005-06-15 2006-12-21 Adelaide Research & Innovation Pty Ltd Combination treatment
WO2007087758A2 (es) * 2006-01-31 2007-08-09 Centro De Ingenieria Genetica Y Biotecnologia Mimotopos de polisacáridos capsulares de neisseria meningitidis y formulaciones farmacéuticas
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11541110B2 (en) 2017-10-13 2023-01-03 The Research Foundation For The State University Of New York Comprehensive vaccine design for commensal disease progression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
JP3221683B2 (ja) * 1994-01-21 2001-10-22 パウダージェクト ヴァクシンズ， インコーポレイテッド ガス駆動型遺伝子搬入装置
WO1997011605A1 (en) * 1995-09-28 1997-04-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
GB9609125D0 (en) * 1996-05-01 1996-07-03 Smithkline Beecham Plc Novel compounds
US6204250B1 (en) * 1996-11-22 2001-03-20 The Mount Sinai Medical Center Of The City Of New York Immunization of infants

Also Published As

Publication number Publication date
JP2002542264A (ja) 2002-12-10
EP1180150A2 (de) 2002-02-20
CA2370646A1 (en) 2000-10-26
WO2000063385A2 (en) 2000-10-26
WO2000063385A3 (en) 2001-02-22
NZ515041A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
ES2523365T3 (es) Expresión híbrida y en tandem de proteínas de Neisseria
ES2337017T3 (es) Procedimiento para obtener respuestas inmunitarias celulares de proteinas.
ES2670196T3 (es) Disolución de polisacáridos capsulares y vacunas de combinación
JP5557415B2 (ja) 吸着させたトキソイドおよび多糖類含有抗原を含む微粒子に基づく免疫原性組成物
JP5832485B2 (ja) 吸着したポリペプチド含有分子を有する微粒子
JP5670003B2 (ja) 血清型ＢおよびＣ由来のＮｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ抗原、ならびにさらなる抗原を含む組成物
US20120171244A1 (en) Mucosal boosting following parenteral priming
BRPI0609460A2 (pt) haemophilus influenzae tipo b
AU4479700A (en) Nucleic acid immunization
EP1379273B1 (de) Nukleinsäureadjuvantien
AU2001297988A1 (en) Nucleic acid adjuvants
US20070237789A1 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US20040082530A1 (en) Nucleic acid immunization
US20050148529A1 (en) Nucleic acid immunization
AU785066B2 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US20060019921A1 (en) Nucleic acid adjuvants